Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4H4Z2
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0006635 | fatty acid beta-oxidation | 6 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009056 | catabolic process | 2 | 1 |
GO:0009062 | fatty acid catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016042 | lipid catabolic process | 4 | 1 |
GO:0016054 | organic acid catabolic process | 4 | 1 |
GO:0019395 | fatty acid oxidation | 5 | 1 |
GO:0019605 | butyrate metabolic process | 6 | 1 |
GO:0019626 | short-chain fatty acid catabolic process | 6 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0030258 | lipid modification | 4 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 7 | 1 |
GO:0034440 | lipid oxidation | 5 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044242 | cellular lipid catabolic process | 4 | 1 |
GO:0044248 | cellular catabolic process | 3 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0044282 | small molecule catabolic process | 3 | 1 |
GO:0046359 | butyrate catabolic process | 7 | 1 |
GO:0046395 | carboxylic acid catabolic process | 5 | 1 |
GO:0046459 | short-chain fatty acid metabolic process | 5 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0072329 | monocarboxylic acid catabolic process | 6 | 1 |
GO:1901575 | organic substance catabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0016491 | oxidoreductase activity | 2 | 12 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0050660 | flavin adenine dinucleotide binding | 4 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0003995 | acyl-CoA dehydrogenase activity | 5 | 1 |
GO:0004085 | butyryl-CoA dehydrogenase activity | 6 | 1 |
GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 308 | 312 | PF00656 | 0.211 |
CLV_C14_Caspase3-7 | 407 | 411 | PF00656 | 0.437 |
CLV_C14_Caspase3-7 | 92 | 96 | PF00656 | 0.387 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.518 |
CLV_NRD_NRD_1 | 37 | 39 | PF00675 | 0.365 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.518 |
CLV_PCSK_KEX2_1 | 261 | 263 | PF00082 | 0.284 |
CLV_PCSK_KEX2_1 | 506 | 508 | PF00082 | 0.351 |
CLV_PCSK_PC1ET2_1 | 261 | 263 | PF00082 | 0.299 |
CLV_PCSK_PC1ET2_1 | 506 | 508 | PF00082 | 0.366 |
CLV_PCSK_SKI1_1 | 118 | 122 | PF00082 | 0.257 |
CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.257 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 208 | 212 | PF00082 | 0.462 |
CLV_PCSK_SKI1_1 | 241 | 245 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 348 | 352 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 464 | 468 | PF00082 | 0.336 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.329 |
CLV_Separin_Metazoa | 515 | 519 | PF03568 | 0.384 |
DEG_APCC_DBOX_1 | 347 | 355 | PF00400 | 0.431 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.566 |
DEG_SPOP_SBC_1 | 319 | 323 | PF00917 | 0.328 |
DOC_CYCLIN_RxL_1 | 461 | 468 | PF00134 | 0.250 |
DOC_MAPK_FxFP_2 | 33 | 36 | PF00069 | 0.323 |
DOC_PP1_SILK_1 | 257 | 262 | PF00149 | 0.295 |
DOC_PP2B_LxvP_1 | 301 | 304 | PF13499 | 0.437 |
DOC_PP4_FxxP_1 | 33 | 36 | PF00568 | 0.323 |
DOC_USP7_MATH_1 | 289 | 293 | PF00917 | 0.261 |
DOC_USP7_MATH_1 | 313 | 317 | PF00917 | 0.373 |
DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.449 |
DOC_USP7_MATH_1 | 408 | 412 | PF00917 | 0.400 |
DOC_USP7_MATH_1 | 451 | 455 | PF00917 | 0.259 |
DOC_USP7_MATH_1 | 501 | 505 | PF00917 | 0.486 |
DOC_WW_Pin1_4 | 222 | 227 | PF00397 | 0.345 |
DOC_WW_Pin1_4 | 331 | 336 | PF00397 | 0.445 |
LIG_14-3-3_CanoR_1 | 14 | 19 | PF00244 | 0.307 |
LIG_14-3-3_CanoR_1 | 2 | 12 | PF00244 | 0.522 |
LIG_14-3-3_CanoR_1 | 200 | 204 | PF00244 | 0.330 |
LIG_14-3-3_CanoR_1 | 241 | 246 | PF00244 | 0.428 |
LIG_14-3-3_CanoR_1 | 26 | 35 | PF00244 | 0.337 |
LIG_14-3-3_CanoR_1 | 348 | 354 | PF00244 | 0.400 |
LIG_14-3-3_CanoR_1 | 378 | 383 | PF00244 | 0.437 |
LIG_14-3-3_CanoR_1 | 56 | 64 | PF00244 | 0.306 |
LIG_14-3-3_CanoR_1 | 68 | 76 | PF00244 | 0.120 |
LIG_Actin_WH2_2 | 252 | 270 | PF00022 | 0.431 |
LIG_APCC_ABBA_1 | 243 | 248 | PF00400 | 0.296 |
LIG_BRCT_BRCA1_1 | 355 | 359 | PF00533 | 0.357 |
LIG_DLG_GKlike_1 | 14 | 22 | PF00625 | 0.347 |
LIG_FHA_1 | 175 | 181 | PF00498 | 0.301 |
LIG_FHA_1 | 200 | 206 | PF00498 | 0.399 |
LIG_FHA_1 | 296 | 302 | PF00498 | 0.443 |
LIG_FHA_1 | 377 | 383 | PF00498 | 0.404 |
LIG_FHA_1 | 466 | 472 | PF00498 | 0.306 |
LIG_FHA_2 | 187 | 193 | PF00498 | 0.462 |
LIG_FHA_2 | 48 | 54 | PF00498 | 0.350 |
LIG_FHA_2 | 498 | 504 | PF00498 | 0.399 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.387 |
LIG_LIR_Apic_2 | 30 | 36 | PF02991 | 0.325 |
LIG_LIR_Gen_1 | 177 | 186 | PF02991 | 0.284 |
LIG_LIR_Gen_1 | 323 | 333 | PF02991 | 0.459 |
LIG_LIR_Gen_1 | 477 | 487 | PF02991 | 0.358 |
LIG_LIR_Nem_3 | 177 | 182 | PF02991 | 0.288 |
LIG_LIR_Nem_3 | 202 | 206 | PF02991 | 0.359 |
LIG_LIR_Nem_3 | 323 | 329 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 370 | 375 | PF02991 | 0.367 |
LIG_LIR_Nem_3 | 502 | 508 | PF02991 | 0.360 |
LIG_LIR_Nem_3 | 71 | 76 | PF02991 | 0.257 |
LIG_MAD2 | 26 | 34 | PF02301 | 0.382 |
LIG_PCNA_yPIPBox_3 | 426 | 437 | PF02747 | 0.243 |
LIG_SH2_CRK | 372 | 376 | PF00017 | 0.468 |
LIG_SH2_CRK | 505 | 509 | PF00017 | 0.384 |
LIG_SH2_CRK | 73 | 77 | PF00017 | 0.257 |
LIG_SH2_SRC | 250 | 253 | PF00017 | 0.291 |
LIG_SH2_STAP1 | 15 | 19 | PF00017 | 0.236 |
LIG_SH2_STAP1 | 252 | 256 | PF00017 | 0.262 |
LIG_SH2_STAP1 | 295 | 299 | PF00017 | 0.268 |
LIG_SH2_STAP1 | 361 | 365 | PF00017 | 0.301 |
LIG_SH2_STAP1 | 449 | 453 | PF00017 | 0.254 |
LIG_SH2_STAT5 | 110 | 113 | PF00017 | 0.278 |
LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.511 |
LIG_SH2_STAT5 | 124 | 127 | PF00017 | 0.189 |
LIG_SH2_STAT5 | 162 | 165 | PF00017 | 0.322 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.296 |
LIG_SH2_STAT5 | 250 | 253 | PF00017 | 0.272 |
LIG_SUMO_SIM_anti_2 | 443 | 449 | PF11976 | 0.182 |
LIG_SUMO_SIM_par_1 | 241 | 248 | PF11976 | 0.280 |
LIG_TRAF2_1 | 138 | 141 | PF00917 | 0.231 |
LIG_UBA3_1 | 256 | 261 | PF00899 | 0.292 |
LIG_UBA3_1 | 51 | 60 | PF00899 | 0.378 |
MOD_CK1_1 | 129 | 135 | PF00069 | 0.266 |
MOD_CK1_1 | 145 | 151 | PF00069 | 0.487 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.419 |
MOD_CK1_1 | 328 | 334 | PF00069 | 0.372 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.458 |
MOD_CK1_1 | 491 | 497 | PF00069 | 0.472 |
MOD_CK1_1 | 93 | 99 | PF00069 | 0.320 |
MOD_CK2_1 | 186 | 192 | PF00069 | 0.489 |
MOD_CK2_1 | 267 | 273 | PF00069 | 0.502 |
MOD_CK2_1 | 349 | 355 | PF00069 | 0.375 |
MOD_CK2_1 | 47 | 53 | PF00069 | 0.296 |
MOD_CK2_1 | 55 | 61 | PF00069 | 0.190 |
MOD_GlcNHglycan | 174 | 177 | PF01048 | 0.255 |
MOD_GlcNHglycan | 207 | 211 | PF01048 | 0.392 |
MOD_GlcNHglycan | 291 | 294 | PF01048 | 0.249 |
MOD_GlcNHglycan | 362 | 365 | PF01048 | 0.424 |
MOD_GlcNHglycan | 405 | 409 | PF01048 | 0.471 |
MOD_GlcNHglycan | 410 | 413 | PF01048 | 0.454 |
MOD_GlcNHglycan | 451 | 454 | PF01048 | 0.267 |
MOD_GlcNHglycan | 6 | 9 | PF01048 | 0.599 |
MOD_GlcNHglycan | 92 | 95 | PF01048 | 0.273 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.166 |
MOD_GSK3_1 | 148 | 155 | PF00069 | 0.355 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.372 |
MOD_GSK3_1 | 325 | 332 | PF00069 | 0.361 |
MOD_GSK3_1 | 349 | 356 | PF00069 | 0.392 |
MOD_GSK3_1 | 404 | 411 | PF00069 | 0.418 |
MOD_GSK3_1 | 449 | 456 | PF00069 | 0.268 |
MOD_GSK3_1 | 497 | 504 | PF00069 | 0.509 |
MOD_GSK3_1 | 89 | 96 | PF00069 | 0.323 |
MOD_N-GLC_1 | 426 | 431 | PF02516 | 0.382 |
MOD_NEK2_1 | 111 | 116 | PF00069 | 0.225 |
MOD_NEK2_1 | 164 | 169 | PF00069 | 0.304 |
MOD_NEK2_1 | 172 | 177 | PF00069 | 0.279 |
MOD_NEK2_1 | 182 | 187 | PF00069 | 0.283 |
MOD_NEK2_1 | 196 | 201 | PF00069 | 0.419 |
MOD_NEK2_1 | 267 | 272 | PF00069 | 0.375 |
MOD_NEK2_1 | 318 | 323 | PF00069 | 0.341 |
MOD_NEK2_1 | 349 | 354 | PF00069 | 0.369 |
MOD_NEK2_1 | 359 | 364 | PF00069 | 0.264 |
MOD_NEK2_1 | 376 | 381 | PF00069 | 0.329 |
MOD_NEK2_1 | 404 | 409 | PF00069 | 0.446 |
MOD_NEK2_1 | 460 | 465 | PF00069 | 0.371 |
MOD_NEK2_1 | 475 | 480 | PF00069 | 0.260 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.242 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.282 |
MOD_NEK2_2 | 313 | 318 | PF00069 | 0.432 |
MOD_PIKK_1 | 136 | 142 | PF00454 | 0.448 |
MOD_PIKK_1 | 184 | 190 | PF00454 | 0.358 |
MOD_PIKK_1 | 426 | 432 | PF00454 | 0.359 |
MOD_PK_1 | 211 | 217 | PF00069 | 0.472 |
MOD_PK_1 | 325 | 331 | PF00069 | 0.232 |
MOD_PKA_2 | 199 | 205 | PF00069 | 0.320 |
MOD_PKA_2 | 267 | 273 | PF00069 | 0.502 |
MOD_PKA_2 | 377 | 383 | PF00069 | 0.443 |
MOD_PKA_2 | 55 | 61 | PF00069 | 0.306 |
MOD_Plk_1 | 145 | 151 | PF00069 | 0.361 |
MOD_Plk_1 | 305 | 311 | PF00069 | 0.373 |
MOD_Plk_1 | 404 | 410 | PF00069 | 0.351 |
MOD_Plk_1 | 501 | 507 | PF00069 | 0.456 |
MOD_Plk_2-3 | 302 | 308 | PF00069 | 0.461 |
MOD_Plk_4 | 106 | 112 | PF00069 | 0.331 |
MOD_Plk_4 | 129 | 135 | PF00069 | 0.300 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.269 |
MOD_Plk_4 | 199 | 205 | PF00069 | 0.307 |
MOD_Plk_4 | 252 | 258 | PF00069 | 0.234 |
MOD_Plk_4 | 305 | 311 | PF00069 | 0.326 |
MOD_Plk_4 | 313 | 319 | PF00069 | 0.259 |
MOD_Plk_4 | 325 | 331 | PF00069 | 0.189 |
MOD_Plk_4 | 349 | 355 | PF00069 | 0.347 |
MOD_Plk_4 | 443 | 449 | PF00069 | 0.293 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.281 |
MOD_Plk_4 | 475 | 481 | PF00069 | 0.395 |
MOD_ProDKin_1 | 222 | 228 | PF00069 | 0.346 |
MOD_ProDKin_1 | 331 | 337 | PF00069 | 0.441 |
MOD_SUMO_for_1 | 469 | 472 | PF00179 | 0.361 |
MOD_SUMO_rev_2 | 89 | 99 | PF00179 | 0.335 |
TRG_DiLeu_BaEn_1 | 370 | 375 | PF01217 | 0.467 |
TRG_DiLeu_BaEn_1 | 443 | 448 | PF01217 | 0.275 |
TRG_DiLeu_BaEn_2 | 354 | 360 | PF01217 | 0.288 |
TRG_ENDOCYTIC_2 | 179 | 182 | PF00928 | 0.407 |
TRG_ENDOCYTIC_2 | 372 | 375 | PF00928 | 0.373 |
TRG_ENDOCYTIC_2 | 505 | 508 | PF00928 | 0.386 |
TRG_ENDOCYTIC_2 | 73 | 76 | PF00928 | 0.242 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.531 |
TRG_Pf-PMV_PEXEL_1 | 38 | 43 | PF00026 | 0.458 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I163 | Leptomonas seymouri | 82% | 100% |
A0A0S4JAW1 | Bodo saltans | 38% | 81% |
A0A1X0NP97 | Trypanosomatidae | 55% | 99% |
A0A3S5H5Y0 | Leishmania donovani | 89% | 100% |
A0A422NAN1 | Trypanosoma rangeli | 56% | 99% |
A4HT68 | Leishmania infantum | 89% | 100% |
B1WC61 | Rattus norvegicus | 28% | 83% |
C9ZUR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AL57 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
P45953 | Rattus norvegicus | 26% | 79% |
P48818 | Bos taurus | 26% | 79% |
P49748 | Homo sapiens | 24% | 79% |
P50544 | Mus musculus | 26% | 79% |
Q4QIP7 | Leishmania major | 89% | 100% |
Q8HXY7 | Macaca fascicularis | 24% | 79% |
Q8JZN5 | Mus musculus | 28% | 83% |
Q9H845 | Homo sapiens | 27% | 84% |
V5BCS4 | Trypanosoma cruzi | 55% | 99% |